Portal de Periódicos da CAPES

Treating Hepatitis C in Lower-Income Countries

2014; Massachusetts Medical Society; Volume: 370; Issue: 20 Linguagem: Inglês

10.1056/nejmp1400160

1533-4406

Channa R. Jayasekera, M. K. Barry, Lewis R. Roberts, Mindie H. Nguyen,

Liver Disease Diagnosis and Treatment

With costs that may exceed $90,000 per course, effective new hepatitis C treatments seem beyond the reach of low- and middle-income countries. But the global rollout of HIV treatment teaches us that it's possible to make these agents broadly available and affordable.